Firm settles FTC charges
This article was originally published in The Tan Sheet
Executive Summary
An FTC order directs Sagee U.S.A. Group to pay $10,000 in redress to settle charges of making false and unsubstantiated claims for its eponymous product. The order includes a $1.38 mil. avalanche clause that would be put into effect if the firm misrepresents its financial state. Original claims stated that Sagee could improve brain health, revitalize and rejuvenate the brain and alleviate or treat a number of serious, chronic brain-related diseases, including schizophrenia, Alzheimer's and Parkinson's disease. The firm advertised the supplement through radio, TV, print and internet media to the Chinese and Vietnamese-speaking communities. The order also requires various recordkeeping provisions to aid FTC in future monitoring the firm's compliance...